Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](SymBio Pharmaceuticals)"
Count: 23
Selected: 0
| NCT ID | Title |
|---|
| NCT03005899 | Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain | ||
| NCT04706923 | A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (ATHENA) | ||
| NCT04542252 | Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects | ||
| NCT04354402 | Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL | ||
| NCT03900377 | Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma | ||
| NCT03604679 | SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors | ||
| NCT03495167 | Study of SyB C-1101 in Patients With Myelodysplastic Syndrome | ||
| NCT03372837 | Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma | ||
| NCT02783547 | Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome | ||
| NCT02042911 | Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia | ||
| NCT02014051 | Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) | ||
| NCT02002936 | Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study | ||
| NCT02000154 | Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study | ||
| NCT01849848 | Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma | ||
| NCT01718691 | Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma | ||
| NCT01700335 | Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) | ||
| NCT01700140 | Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV) | ||
| NCT01179490 | Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma | ||
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT00794638 | A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma | ||
| NCT00612183 | Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma | ||
| NCT00389051 | A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma | ||
| NCT01650051 | Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI) |
